Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| 製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
|---|---|---|---|---|---|
| CHEK-ATP213 | Human | HEK293/Human SSTR2 Stable Cell Line | |||
| SS2-HF2G3 | Human | Fluorescent Human SSTR2 Full Length Protein (VLP) | |||
| SS2-H5216 | Human | Human SSTR2 Full Length Protein (VLP) |
Immobilized Human SSTR2 Full Length Protein-VLP (Cat. No. SS2-H5216) at 5 μg/mL (100 μL/well) can bind Anti-SSTR2 Antibody, Human IgG1 with a linear range of 0.3-5 ng/mL (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Pasireotide Pamoate | Approved | Novartis Pharma Ag | Signifor lar | United States | Acromegaly | Recordati Rare Diseases Inc | 2014-12-15 | Gigantism; Acromegaly; Cushing Syndrome; Carcinoid Tumor; Pituitary ACTH Hypersecretion; Neuroendocrine Tumors; Meningioma | Details | |
| Lutetium (177Lu) oxodotreotide | [Lu-177]-DOTATATE; AAA-601; XTR-008; 177Lu-DOTATATE; Lu-DOTATATE; F-1515 | Approved | Advanced Accelerator Applications Sa | Lutathera | EU | Neuroendocrine Tumors | Advanced Accelerator Applications Sa | 2017-09-26 | Prostatic Neoplasms; Carcinoid Heart Disease; Meningioma; Paraganglioma; Gastrointestinal Neoplasms; Carcinoma, Neuroendocrine; Lung Neoplasms; Pituitary Neoplasms; Breast Neoplasms; Neuroblastoma; Medullary thyroid cancer (MTC); Leiomyosarcoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Adenoma, Islet Cell; Malignant Carcinoid Syndrome; Pancreatic neuroendocrine tumors (pNET); Carcinoid Tumor; Bronchial Neoplasms; Pheochromocytoma; Stomach Neoplasms; Liver Neoplasms | Details |
| Vapreotide Acetate | RC-160; BMY-41606 | Approved | Debiopharm Group | Sanvar, Docrised, Sanvar IR, Sanvar SR | Acromegaly; Hypertension, Portal; Pancreatic Neoplasms; Hemorrhage; Neuroendocrine Tumors; Diarrhea; Intraoperative Complications; Postoperative Complications; Esophageal and Gastric Varices; Crohn Disease | Details | ||||
| Pasireotide Diaspartate | SOM-230; SOM-230C; SOM-320 | Approved | Novartis Pharma Ag | Signifor, 丝尼芬 | EU | Cushing Syndrome | Recordati Rare Diseases Inc | 2012-04-24 | Pituitary Neoplasms; Uveal melanoma; Prostatic Neoplasms, Castration-Resistant; Cysts; Pituitary ACTH Hypersecretion; Medullary thyroid cancer (MTC); Prostatic Neoplasms; Hyperinsulinism; Nelson Syndrome; Multiple Myeloma; Thyroid Neoplasms; Thymoma; Meningioma; Prolactinoma; Gastrointestinal Neoplasms; Carcinoma, Hepatocellular; Cluster Headache; Acromegaly; Neuroendocrine Tumors; Liver Cirrhosis; Kidney Diseases; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Neoplasms; Adenoma, Islet Cell; Hypoglycemia; Dumping Syndrome; Insulinoma; Carcinoid Tumor; Cushing Syndrome; Alcohol-Induced Disorders; Congenital Hyperinsulinism; ACTH Syndrome, Ectopic | Details |
| Ga-68 Edotreotide | SMT-487; [68Ga]DOTATOC; 90Y-DOTATOC | Approved | Advanced Accelerator Applications Sa | SomaKit TOC, Gallium Dotatoc Ga 68, TOCscan | EU | Diagnostic agents; Neuroendocrine Tumors; Pancreatic neuroendocrine tumors (pNET) | Advanced Accelerator Applications Sa | 2016-12-08 | Medulloblastoma; Multiple Endocrine Neoplasia Type 1; Carcinoid Tumor; Pancreatic neuroendocrine tumors (pNET); Neuroendocrine Tumors; Neuroblastoma; Pituitary Neoplasms; Diagnostic agents; von Hippel-Lindau Disease; Somatostatinoma; Meningioma; Paraganglioma | Details |
| Gallium (68Ga) oxodotreotide | 68Ga-DOTA-TATE; 68-Ga-DOTA-TATE | Approved | Advanced Accelerator Applications Sa | Netspot | United States | Neuroendocrine Tumors | Aaa Usa Inc | 2016-06-01 | Pheochromocytoma; Carcinoid Tumor; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Neuroendocrine Tumors; Prostatic Neoplasms; Thyroid Neoplasms; Carcinoma, Neuroendocrine; von Hippel-Lindau Disease; Paraganglioma; Carcinoma, Hepatocellular | Details |
| Pasireotide Pamoate | Approved | Novartis Pharma Ag | Signifor lar | United States | Acromegaly | Recordati Rare Diseases Inc | 2014-12-15 | Gigantism; Acromegaly; Cushing Syndrome; Carcinoid Tumor; Pituitary ACTH Hypersecretion; Neuroendocrine Tumors; Meningioma | Details | |
| Lutetium (177Lu) oxodotreotide | [Lu-177]-DOTATATE; AAA-601; XTR-008; 177Lu-DOTATATE; Lu-DOTATATE; F-1515 | Approved | Advanced Accelerator Applications Sa | Lutathera | EU | Neuroendocrine Tumors | Advanced Accelerator Applications Sa | 2017-09-26 | Prostatic Neoplasms; Carcinoid Heart Disease; Meningioma; Paraganglioma; Gastrointestinal Neoplasms; Carcinoma, Neuroendocrine; Lung Neoplasms; Pituitary Neoplasms; Breast Neoplasms; Neuroblastoma; Medullary thyroid cancer (MTC); Leiomyosarcoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Adenoma, Islet Cell; Malignant Carcinoid Syndrome; Pancreatic neuroendocrine tumors (pNET); Carcinoid Tumor; Bronchial Neoplasms; Pheochromocytoma; Stomach Neoplasms; Liver Neoplasms | Details |
| Vapreotide Acetate | RC-160; BMY-41606 | Approved | Debiopharm Group | Sanvar, Docrised, Sanvar IR, Sanvar SR | Acromegaly; Hypertension, Portal; Pancreatic Neoplasms; Hemorrhage; Neuroendocrine Tumors; Diarrhea; Intraoperative Complications; Postoperative Complications; Esophageal and Gastric Varices; Crohn Disease | Details | ||||
| Pasireotide Diaspartate | SOM-230; SOM-230C; SOM-320 | Approved | Novartis Pharma Ag | Signifor, 丝尼芬 | EU | Cushing Syndrome | Recordati Rare Diseases Inc | 2012-04-24 | Pituitary Neoplasms; Uveal melanoma; Prostatic Neoplasms, Castration-Resistant; Cysts; Pituitary ACTH Hypersecretion; Medullary thyroid cancer (MTC); Prostatic Neoplasms; Hyperinsulinism; Nelson Syndrome; Multiple Myeloma; Thyroid Neoplasms; Thymoma; Meningioma; Prolactinoma; Gastrointestinal Neoplasms; Carcinoma, Hepatocellular; Cluster Headache; Acromegaly; Neuroendocrine Tumors; Liver Cirrhosis; Kidney Diseases; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Neoplasms; Adenoma, Islet Cell; Hypoglycemia; Dumping Syndrome; Insulinoma; Carcinoid Tumor; Cushing Syndrome; Alcohol-Induced Disorders; Congenital Hyperinsulinism; ACTH Syndrome, Ectopic | Details |
| Ga-68 Edotreotide | SMT-487; [68Ga]DOTATOC; 90Y-DOTATOC | Approved | Advanced Accelerator Applications Sa | SomaKit TOC, Gallium Dotatoc Ga 68, TOCscan | EU | Diagnostic agents; Neuroendocrine Tumors; Pancreatic neuroendocrine tumors (pNET) | Advanced Accelerator Applications Sa | 2016-12-08 | Medulloblastoma; Multiple Endocrine Neoplasia Type 1; Carcinoid Tumor; Pancreatic neuroendocrine tumors (pNET); Neuroendocrine Tumors; Neuroblastoma; Pituitary Neoplasms; Diagnostic agents; von Hippel-Lindau Disease; Somatostatinoma; Meningioma; Paraganglioma | Details |
| Gallium (68Ga) oxodotreotide | 68Ga-DOTA-TATE; 68-Ga-DOTA-TATE | Approved | Advanced Accelerator Applications Sa | Netspot | United States | Neuroendocrine Tumors | Aaa Usa Inc | 2016-06-01 | Pheochromocytoma; Carcinoid Tumor; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Neuroendocrine Tumors; Prostatic Neoplasms; Thyroid Neoplasms; Carcinoma, Neuroendocrine; von Hippel-Lindau Disease; Paraganglioma; Carcinoma, Hepatocellular | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Paltusotine | CRN-00808 | Phase 3 Clinical | Crinetics Pharmaceuticals Inc | Acromegaly; Malignant Carcinoid Syndrome; Neuroendocrine Tumors | Details |
| Lutetium-177 labelled edotreotide | ITM-11 | Phase 3 Clinical | Universitaetsspitals Basel, Itm Solucin Gmbh | Pancreatic neuroendocrine tumors (pNET); Neuroendocrine Tumors; Thymus Neoplasms; Lung Neoplasms | Details |
| RYZ-101 | RYZ-101 | Phase 3 Clinical | Carcinoid Tumor; Stomach Neoplasms; Pancreatic neuroendocrine tumors (pNET); Small Cell Lung Carcinoma; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Gastrointestinal Neoplasms | Details | |
| Gallium-68 satoreotide | 68Ga-OPS-202; 68Ga IPN-1070; 68Ga-DOTA-JR11 | Phase 2 Clinical | Ipsen Inc | Stomach Neoplasms; Pancreatic neuroendocrine tumors (pNET); Small Cell Lung Carcinoma; Breast Neoplasms; Gastrointestinal Neoplasms | Details |
| Nendratareotide uzatansine | BTP-277; PEN-221 | Phase 2 Clinical | Tarveda Therapeutics Inc | Small Cell Lung Carcinoma; Neuroendocrine Tumors; Carcinoma, Neuroendocrine | Details |
| Yttrium 90-labelled edotreotide | SMT-487-[90Y]; DOTATOC-[90Y] | Phase 2 Clinical | The University Of Iowa, Novartis Pharma Ag | Central Nervous System Neoplasms; Meningioma; Melanoma; Lymphoma; Lung Neoplasms; Sarcoma; Neuroblastoma; Breast Neoplasms; Brain Neoplasms; Solid tumours; Neuroendocrine Tumors; Small Cell Lung Carcinoma; Adenoma, Islet Cell; Neoplasms; Pheochromocytoma; Carcinoid Tumor; Medulloblastoma | Details |
| Dopastatin | TBR-760; BIM-23A760 | Phase 2 Clinical | Ipsen | Acromegaly; Malignant Carcinoid Syndrome; Adenoma; Pituitary Neoplasms | Details |
| ZT-01 | ZT 01; ZT-01 | Phase 2 Clinical | Tulane University, York University, University Of Toronto, Toronto | Diabetes Mellitus, Type 1; Hypoglycemia | Details |
| Re-188 P 2045 | P2045; BAY-865284; Rhenium-188 P2045; Re-188 P 2045; Rh-188 P2045; Rhenium-188-P-2045 | Phase 2 Clinical | Bayer AG | Neoplasm Recurrence, Local; Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lung Neoplasms; Carcinoma, Small Cell; Carcinoma, Non-Small-Cell Lung | Details |
| 64Cu-SarTate | Phase 2 Clinical | University Of Melbourne | Neuroendocrine Tumors; Neuroblastoma; Meningioma | Details | |
| Lutetium-177 DOTA satoreotide | [177Lu]LuSSO110; 177Lu-IPN-1072; OPS-201; 177Lu-IPN01072; 177LU-OPS 201; 177Lu-DOTA- JR11; 177Lu-satoreotide | Phase 1 Clinical | Ipsen, OctreoPharm Sciences GmbH | Small Cell Lung Carcinoma; Breast Neoplasms; Meningioma | Details |
| CRN-01941 | CRN-01941 | Phase 1 Clinical | Crinetics Pharmaceuticals Inc | Details | |
| 68Ga-NOTA-3PTATE-RGD | 68Ga-NOTA-3PTATE-RGD; 68Ga-NOTA-3P-TATE-RGD | Phase 1 Clinical | Peking Union Medical College Hospital | Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lung Neoplasms | Details |
| [99mTc]Tc-TECANT1 | Phase 1 Clinical | Ljubljana University Medical Centre, Medical University Of Innsbruck, Narodowe Centrum Badan Jadrowych, Jagiellonian University Sylff Fellows Association | Neuroendocrine Tumors | Details | |
| 161Tb-DOTA-LM3 | 161Tb-DOTA-LM3 | Phase 1 Clinical | University Hospital Basel | Pancreatic neuroendocrine tumors (pNET); Neuroendocrine Tumors | Details |
| [203-Pb] VMT-NET | [203-Pb] VMT-NET | Phase 1 Clinical | Perspective Therapeutics Inc | Neuroendocrine Tumors | Details |
| 44Sc-edotreotide | 44Sc-edotreotide; 44Sc-DOTA-[3-Tyr]-octreotide; Sc44-DOTATOC | Clinical | Zentralklinik Bad Berka | Diagnostic agents | Details |
| Paltusotine | CRN-00808 | Phase 3 Clinical | Crinetics Pharmaceuticals Inc | Acromegaly; Malignant Carcinoid Syndrome; Neuroendocrine Tumors | Details |
| Lutetium-177 labelled edotreotide | ITM-11 | Phase 3 Clinical | Universitaetsspitals Basel, Itm Solucin Gmbh | Pancreatic neuroendocrine tumors (pNET); Neuroendocrine Tumors; Thymus Neoplasms; Lung Neoplasms | Details |
| RYZ-101 | RYZ-101 | Phase 3 Clinical | Carcinoid Tumor; Stomach Neoplasms; Pancreatic neuroendocrine tumors (pNET); Small Cell Lung Carcinoma; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Gastrointestinal Neoplasms | Details | |
| Gallium-68 satoreotide | 68Ga-OPS-202; 68Ga IPN-1070; 68Ga-DOTA-JR11 | Phase 2 Clinical | Ipsen Inc | Stomach Neoplasms; Pancreatic neuroendocrine tumors (pNET); Small Cell Lung Carcinoma; Breast Neoplasms; Gastrointestinal Neoplasms | Details |
| Nendratareotide uzatansine | BTP-277; PEN-221 | Phase 2 Clinical | Tarveda Therapeutics Inc | Small Cell Lung Carcinoma; Neuroendocrine Tumors; Carcinoma, Neuroendocrine | Details |
| Yttrium 90-labelled edotreotide | SMT-487-[90Y]; DOTATOC-[90Y] | Phase 2 Clinical | The University Of Iowa, Novartis Pharma Ag | Central Nervous System Neoplasms; Meningioma; Melanoma; Lymphoma; Lung Neoplasms; Sarcoma; Neuroblastoma; Breast Neoplasms; Brain Neoplasms; Solid tumours; Neuroendocrine Tumors; Small Cell Lung Carcinoma; Adenoma, Islet Cell; Neoplasms; Pheochromocytoma; Carcinoid Tumor; Medulloblastoma | Details |
| Dopastatin | TBR-760; BIM-23A760 | Phase 2 Clinical | Ipsen | Acromegaly; Malignant Carcinoid Syndrome; Adenoma; Pituitary Neoplasms | Details |
| ZT-01 | ZT 01; ZT-01 | Phase 2 Clinical | Tulane University, York University, University Of Toronto, Toronto | Diabetes Mellitus, Type 1; Hypoglycemia | Details |
| Re-188 P 2045 | P2045; BAY-865284; Rhenium-188 P2045; Re-188 P 2045; Rh-188 P2045; Rhenium-188-P-2045 | Phase 2 Clinical | Bayer AG | Neoplasm Recurrence, Local; Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lung Neoplasms; Carcinoma, Small Cell; Carcinoma, Non-Small-Cell Lung | Details |
| 64Cu-SarTate | Phase 2 Clinical | University Of Melbourne | Neuroendocrine Tumors; Neuroblastoma; Meningioma | Details | |
| Lutetium-177 DOTA satoreotide | [177Lu]LuSSO110; 177Lu-IPN-1072; OPS-201; 177Lu-IPN01072; 177LU-OPS 201; 177Lu-DOTA- JR11; 177Lu-satoreotide | Phase 1 Clinical | Ipsen, OctreoPharm Sciences GmbH | Small Cell Lung Carcinoma; Breast Neoplasms; Meningioma | Details |
| CRN-01941 | CRN-01941 | Phase 1 Clinical | Crinetics Pharmaceuticals Inc | Details | |
| 68Ga-NOTA-3PTATE-RGD | 68Ga-NOTA-3PTATE-RGD; 68Ga-NOTA-3P-TATE-RGD | Phase 1 Clinical | Peking Union Medical College Hospital | Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lung Neoplasms | Details |
| [99mTc]Tc-TECANT1 | Phase 1 Clinical | Ljubljana University Medical Centre, Medical University Of Innsbruck, Narodowe Centrum Badan Jadrowych, Jagiellonian University Sylff Fellows Association | Neuroendocrine Tumors | Details | |
| 161Tb-DOTA-LM3 | 161Tb-DOTA-LM3 | Phase 1 Clinical | University Hospital Basel | Pancreatic neuroendocrine tumors (pNET); Neuroendocrine Tumors | Details |
| [203-Pb] VMT-NET | [203-Pb] VMT-NET | Phase 1 Clinical | Perspective Therapeutics Inc | Neuroendocrine Tumors | Details |
| 44Sc-edotreotide | 44Sc-edotreotide; 44Sc-DOTA-[3-Tyr]-octreotide; Sc44-DOTATOC | Clinical | Zentralklinik Bad Berka | Diagnostic agents | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
